An encyclopedia of clinical-stage biotech, distilled.

Programs, indications, targets, and development stage for 133 small- and mid-cap biotech companies — extracted from SEC filings and refreshed weekly.

133 companies · 839 active programs · 13 therapeutic areas · 422 targets